Precision medicine for cancer patients: worth a special issue Klaus Höffken Editorial 13 January 2023 Pages: 1 - 1
Quo vadis precision oncology? Kathrin HeinrichC. Benedikt Westphalen Guest Editorial Open access 13 January 2023 Pages: 3 - 4
Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis Chi-Lu ChiangHsiang-Ling HoTeh-Ying Chou Research 01 November 2022 Pages: 5 - 14
High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD) Lizong WangYi CaoJingyun Xu Research Open access 29 September 2022 Pages: 15 - 24
Risk of cancer in individuals with Lynch-like syndrome and their families: a systematic review Pandu P. NugrohoSiti Alyaa S. GhozaliJeanette C. Reece Research Open access 17 October 2022 Pages: 25 - 46
Identification and validation of RNA methylation-related alternative splicing gene signature for low-grade glioma to predict survival and immune landscapes Chenggong MaYunong BaoHui Li Research 18 December 2022 Pages: 47 - 62
RETRACTED ARTICLE: The role of lymph node dissection in the surgical treatment of endometrial cancer patients (retrospective analysis) Oksana MovchanValentin Svintsitskyi Research 11 October 2022 Pages: 63 - 68
Mutational profiles of head and neck squamous cell carcinomas based upon human papillomavirus status in the Veterans Affairs National Precision Oncology Program Steven DoerstlingDavid WinskiVishal Vashistha Research 18 September 2022 Pages: 69 - 77
HAPLN3 inhibits apoptosis and promotes EMT of clear cell renal cell carcinoma via ERK and Bcl-2 signal pathways Yi DingShida XiongJu Guo Research 14 November 2022 Pages: 79 - 90
Computer-aided detection and prognosis of colorectal cancer on whole slide images using dual resolution deep learning Yan XuLiwen JiangJiangyu Zhang Research 04 November 2022 Pages: 91 - 101
A single-center experience with linear accelerator-based stereotactic radiotherapy for meningiomas: hypofractionation and radiosurgery Ahmed GawishNurlan AbdulayevThomas B. Brunner Research Open access 28 October 2022 Pages: 103 - 109
Outcome and characteristics of patients with adult grade 4 diffuse gliomas changing sites of treatment Marie-Therese ForsterMarion HugJoachim P. Steinbach Research Open access 08 November 2022 Pages: 111 - 119
miRNA-223-3p regulates ECT2 to promote proliferation, invasion, and metastasis of gastric cancer through the Wnt/β-catenin signaling pathway Lin LiPengwei LiuChunfang Xu Research 10 November 2022 Pages: 121 - 134
A telomerase regulation-related lncRNA signature predicts prognosis and immunotherapy response for gastric cancer Jinggao FengXiayu TangYao Huang Research 05 November 2022 Pages: 135 - 146
The rs1801280 SNP is associated with non-small cell lung carcinoma by exhibiting a highly deleterious effect on N-acetyltransferase 2 Zahraa K. LawiMohammed Baqur S. Al-ShuhaibIbtissem Ben Amara Research 01 September 2022 Pages: 147 - 157
Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer Green HongPureum SunDa Hyun Kang Research Open access 06 December 2022 Pages: 159 - 171
Diagnostic, prognostic, and immunological roles of CD177 in cervical cancer Wenxin LiaoWei LiFujin Shen Research 09 November 2022 Pages: 173 - 189
Systemic immune-inflammation index during treatment predicts prognosis and guides clinical treatment in patients with nasopharyngeal carcinoma Xiaofei YuanHuiru FengFan Wang Research Open access 03 January 2023 Pages: 191 - 202
A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer Xu JiangJing KeWei Yuan Research 14 November 2022 Pages: 203 - 218
Curcumin combined with arsenic trioxide in the treatment of acute myeloid leukemia: network pharmacology analysis and experimental validation Ying-jian ZengFan LiuZhen-hui Wu Research 09 November 2022 Pages: 219 - 230
Identification of molecular subtypes based on chromatin regulator and tumor microenvironment infiltration characterization in papillary renal cell carcinoma Qilin TangDeshen PanLei Chen Research 20 November 2022 Pages: 231 - 245
Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC Meng WangLiu LiuGang Huang Research Open access 24 December 2022 Pages: 247 - 261
Prognostic evaluation based on radiological morphological characteristic for tumors larger than 7 cm in renal cell carcinoma Jiaqi HuangChenchen DaiHang Wang Research 15 December 2022 Pages: 263 - 270
Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144 Ioannis PoziosNina A. HeringHendrik Seeliger Research Open access 10 December 2022 Pages: 271 - 280
Construction of noninvasive prognostic model of bladder cancer patients based on urine proteomics and screening of natural compounds Shun WanJinlong CaoLi Yang Research 23 December 2022 Pages: 281 - 296
Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo M. HouwelingU. K. AbdulB. A. Westerman Research 01 December 2022 Pages: 297 - 305
Novel immunogenic cell death-related risk signature to predict prognosis and immune microenvironment in lung adenocarcinoma Qixuan LiYijie TangJiahai Shi Research 28 December 2022 Pages: 307 - 323
A diagnostic miRNA panel to detect recurrence of ovarian cancer through artificial intelligence approaches Reyhaneh AghayousefiSeyed Mahdi Hosseiniyan KhatibiMohammad Teshnehlab Research 15 November 2022 Pages: 325 - 341
Genome-wide DNA methylation profile analysis identifies an individualized predictive signature for melanoma immune response Junya YanXiaowen WuShundong Cang Research 03 January 2023 Pages: 343 - 356
Research on the influence of APOBEC family on the occurrence, diagnosis, and treatment of various tumors Jing YangJiali HouMengxia Li Review 12 October 2022 Pages: 357 - 366
Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents Disha ShahAjazuddinSankha Bhattacharya Review 21 October 2022 Pages: 367 - 391
Role of smartphone devices in precision oncology Ruby Srivastava Review 17 October 2022 Pages: 393 - 400
Long non-coding RNAs involved in retinoblastoma Ava NasrolahiShirin AzizidoostMostafa Feghhi Review 28 October 2022 Pages: 401 - 421
Tumor-derived miRNAs as tumor microenvironment regulators for synergistic therapeutic options Qiuxing MengYaoming DengShifu Tang Review 15 November 2022 Pages: 423 - 439
Implication of gut microbes and its metabolites in colorectal cancer Arun KumarAsgar AliSundeep Singh Saluja Review 27 December 2022 Pages: 441 - 465
Predictive biomarkers in gastric cancer C. Röcken Review Open access 19 October 2022 Pages: 467 - 481
The dual role and mutual dependence of heme/HO-1/Bach1 axis in the carcinogenic and anti-carcinogenic intersection Jinjing XuKuiyang ZhuJing Chen Review 31 October 2022 Pages: 483 - 501
Applications of artificial intelligence multiomics in precision oncology Ruby Srivastava Review 07 July 2022 Pages: 503 - 510
Understanding the regulation of “Don’t Eat-Me” signals by inflammatory signaling pathways in the tumor microenvironment for more effective therapy Ashkan Zare KarizakZahra SalmasiAmir Savardashtaki Review 07 November 2022 Pages: 511 - 529
Conventional and drug-eluting beads transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a systematic review and pooled analysis Meiya HeNan JiangKetao Mu Review 19 November 2022 Pages: 531 - 540
Gut microbiota: a potential target for improved cancer therapy Mingkuan ZhaoGen JiangJie Zhou Review 23 December 2022 Pages: 541 - 552
